Britain says the coronavirus vaccine, if successful, will be available this autumn!

May 22, 2020/PRNewswire
BIOON/22 --Scientists at Oxford University have begun aclinical trial of a coronavirus vaccine that has shown hope in rhesus monkeys, according to news reportsIf the vaccine is effective in protecting humans from the new coronavirus (SARS-CoV-2), the first injection could take place in the fall, according to a blog post on the official trial pagethe vaccine is made up of a weakened version of a common cold virus called adenovirus, which causes chimps to contractBut according to a statement, the virus has been genetically modified to make it "impossible" to grow in the human bodyThey then combine the weakened adenovirus with the gene that encodes the coronavirus "sudden" protein, which is the protein used by SARS-CoV-2 to infect human cellsaccording to the statement, the vaccine will theoretically train the body to identify and develop an immune response to the protoprotein, thereby preventing the SARS-CoV-2 virus from entering human cellsimage source: https://cn.bing.com
a similar vaccine -- the same weakened version of chimpanzee adenovirus -- has been injected with more than 320 peopleSo far, it has been shown to be "safe and tolerable, except for temporary side effects such as fever, headache and arm aches." Thetrial, which began on 23 April, will eventually recruit up to 1,102 health participants in Oxford, Southampton, London and BristolHalf of the participants will receive a new vaccine; most of them will receive one dose, but 10 of them will receive a second dose in a month' timeThe other half of the participants will receive a "control" vaccine -- approved and routinely used in adolescents since 2015 -- to prevent meningitis and septicaemiaresearchers decided to use the control vaccine, not just saline solution, because participants could not guess whether they had the real vaccineThe researchers expect the new coronavirus vaccine to cause temporary side effects, such as arm soreness, headache and fever, which are also expected to appear in the control vaccine but not in saline solutions the trial will last six months and will be available one year after vaccination "Ideally, by the fall of 2020, we can get effective results from Phase III trials that the vaccine can prevent viruses and have the ability to produce large numbers of vaccines, but these best time frames are very ambitious and could change." "
of course, it's too early to tell if the vaccine is effective, but according to the New York Times, it has shown hope in rhesus monkeys The researchers vaccinated six rhesus monkeys at the Rocky Mountain Laboratory at the Montana National Institutes of Health The researchers then exposed them to a large number of coronaviruses, the Times reported After 28 days, all six monkeys recovered another vaccine is made from an inactivated coronavirus, and according to a previous live scientific report, hope has been shown in monkeys in China Researchers in China are currently conducting human clinical trials the vaccine According to the World Health Organization, more than 70 other vaccines are being developed worldwide (Bio ValleyBioon.com) References: 1
Coronavirus vaccine development in UK can be ready by fall, if it works
2 how long will it take to get the Oxford vaccine to deployment? 3 The Oxford Vaccine Centre COVID-19 Phase I Clinical Trial New COVID-19 vaccine show promise in monkeys Next step: humans